angiotensin ii has been researched along with A-V Dissociation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darbar, D; Donahue, BS; Ellinor, PT; Kaiser, DW; Kannankeril, PJ; MacRae, CA; Makino, S; Roden, DM; Wasserman, BS; Watanabe, H | 1 |
| Leunissen, JD; Londoño, C; Ramakers, C; Schoenmakers, M; van Opstal, JM; Vos, MA | 1 |
| Goette, A; Lendeckel, U | 1 |
| Bernstein, KE; Campbell, DJ; Capecchi, MR; Dudley, SC; Fuchs, S; Hoit, BD; Kasi, VS; Keshelava, G; Lewis, W; Xiao, HD; Zhao, H | 1 |
| Allessie, M; Blaauw, Y; Eijsbouts, S; Neuberger, HR; Schotten, U; van Hunnik, A; Verheule, S | 1 |
| Bourgeois, MJ; Donald, DE; Gilbert, BK; Wood, EH | 1 |
6 other study(ies) available for angiotensin ii and A-V Dissociation
| Article | Year |
|---|---|
ACE I/D polymorphism associated with abnormal atrial and atrioventricular conduction in lone atrial fibrillation and structural heart disease: implications for electrical remodeling.
Topics: Adult; Angiotensin II; Atrial Fibrillation; Atrioventricular Node; Case-Control Studies; Cohort Studies; Female; Heart Atria; Heart Block; Heart Diseases; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Ventricular Remodeling | 2009 |
Asynchronous development of electrical remodeling and cardiac hypertrophy in the complete AV block dog.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Bradycardia; Chymases; Dose-Response Relationship, Drug; Female; Heart Block; Humans; Hypertrophy, Left Ventricular; Irbesartan; Male; Peptidyl-Dipeptidase A; Phenethylamines; Potassium Channel Blockers; Serine Endopeptidases; Sulfonamides; Tetrazoles; Torsades de Pointes | 2003 |
Tachycardia-induced remodeling: atria and ventricles take a different route.
Topics: Angiotensin II; Animals; Apoptosis; Dogs; Electrocardiography; Fibrosis; Heart Atria; Heart Block; Heart Ventricles; Humans; MAP Kinase Signaling System; Tachycardia; Ventricular Remodeling | 2004 |
Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death.
Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Blood Pressure; Bradykinin; Death, Sudden; Disease Models, Animal; Female; Gene Targeting; Heart Block; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myosin Heavy Chains; Peptidyl-Dipeptidase A; Promoter Regions, Genetic; Recombination, Genetic; Tissue Distribution | 2004 |
Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Fibrillation; Atrial Natriuretic Factor; Cardiac Pacing, Artificial; Cardiomegaly; Cell Size; Chronic Disease; Connexin 43; Connexins; Female; Gap Junction alpha-5 Protein; Goats; Heart Block; Heart Conduction System; Hemodynamics; Hypertrophy; Myocytes, Cardiac; Neural Conduction; Norepinephrine; Refractory Period, Electrophysiological | 2005 |
Characteristics of aortic diastolic pressure decay with application to the continuous monitoring of changes in peripheral vascular resistance.
Topics: Acetylcholine; Anesthesia, Intravenous; Angiotensin II; Animals; Aorta; Aorta, Thoracic; Blood Pressure; Cardiac Catheterization; Cardiac Output; Computers; Dogs; Dye Dilution Technique; Electrocardiography; Electronics, Medical; Heart Block; Heart Rate; Morphine; Pentobarbital; Pressure; Regional Blood Flow; Rheology; Vascular Resistance | 1974 |